Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Niet-invasieve diagnose 'Pneumocystis jirovecii'-pneumonie: een systematische review en meta-analyse
mrt 2022 | HIV, Pneumonie, Schimmelinfecties